Evidence map›Paper›PMID 31896555›Full record

ArticleImmunoHorizons2020

Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4

Samuel J Hobbs, Jake C Harbour, Phillip A Yates, Diana Ortiz, Scott M Landfear, Jeffrey C Nolz

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. T helper 1 effector memory CD4Cell reports · 2023
    Article
  3. Article
  4. Design and Immunological Validation ofFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samuel J HobbsDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0002-4282-8813
Jake C HarbourDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0003-2485-3932
Phillip A YatesDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0003-2016-9789
Diana OrtizDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0001-6492-8842
Scott M LandfearDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0002-1643-6664
Jeffrey C NolzDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239; nolz@ohsu.edu.
Oregon Health & Science University · US

Funding

INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
REGULATION OF MEMORY T CELL TRAFFICKING BY CORE 2 O-GLYCAN SYNTHESISR01AI132404 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI NOLZ, JEFFREY C. · 2017 to 2021
$2.0M
Development of Novel Therapeutics for LeishmaniasisR33AI127591 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI GUY, RODNEY KIPLIN, LANDFEAR, SCOTT M · 2019 to 2021
$1.4M
Regulation of tissue-resident memory CD8+ T cell differentiation following antigen recognitionF31AI140525 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HOBBS, SAMUEL JAMES · 2019 to 2019
$44k
NIAID NIH HHS F31 AI140525NIAID NIH HHS R01 AI132404NIAID NIH HHS R33 AI127591NIAID NIH HHS T32 AI007472
6 · The paper itself

Abstract

CD4

Indexed as

Adaptive ImmunityAnimalsAntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHistocompatibility Antigens Class IIImmunodominant EpitopesMiceMice, Inbred C57BLPeptidesVaccinia virusAntigensEpitopes, T-LymphocyteHistocompatibility Antigens Class IIImmunodominant EpitopesPeptides

Identifiers

PMID31896555
PMCPMC7380490
OpenAlexW2998348209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.